On September 23, BioStock’s event Investing in Life Science 2025 took place in Stockholm. It was a day full of insights, inspiration, innovation and panel discussions.
Abarceo’s CEO Adam Bruce attended the event and presented Abarceo’s development toward creating a revolutionary new treatment for Diabetes patients to restoring the patients own ability to produce insulin to the investor community.
Recent Comments